Real Time fMRI & Quitting Smoking

Status Completed

Clinical Trial Summary

This study will examine how real-time functional magnetic resonance imaging (rt-fMRI) feedback can be used to modulate brain activation in the context of smoking cues in order to resist craving. Participants will complete a total of three fMRI scanning sessions with a cue suppression task with or without neurofeedback training (NFT). Participants will be randomized to an active group (active NFT) or a control group (no NFT) during the scanning sessions. At the end of the third session, all participants will complete a validated smoking lapse laboratory paradigm to evaluate effects of NFT on smoking behavior.

Clinical Trial Description

Smoking is the greatest preventable cause of mortality and a significant economic burden. Even with the best available treatments, most smokers relapse within days or weeks after a quit attempt. Nicotine replacement therapy, the most widely used pharmacotherapy, yields end of treatment quit rates of <25% suggesting that managing nicotine withdrawal is not sufficient. A smoker's response to smoking cues is one factor that increases risk of relapse. This study will examine how real-time functional magnetic resonance imaging (rt-fMRI) feedback can be used to modulate brain activation in the context of smoking cues in order to resist craving. First, we will conduct a pilot study in 12 smokers for technical development and to evaluate the feasibility of the proposed study procedures. Participants will complete a total of three fMRI scanning sessions with a cue suppression task with or without neurofeedback training (NFT). Participants will be randomized to an active group (active NFT) or a control group (no NFT) during the scanning sessions. At the end of the third session, all participants will complete a validated smoking lapse laboratory paradigm to evaluate effects of NFT on smoking behavior. Upon successful completion of the technical development phase, we will proceed to a proof-of-concept phase, which will recruit 72 smokers to evaluate the efficacy of NFT for smoking behavior. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03302026
Study type	Interventional
Source	University of Pennsylvania
Contact
Status	Completed
Phase	N/A
Start date	January 2, 2018
Completion date	March 28, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04284813` - Families With Substance Use and Psychosis: A Pilot Study	N/A
Completed	`NCT02511704` - Pharmacokinetics and Acute Effects of Multiple Dose of Nicotine: Electronic Cigarette and Cigarette	Phase 1
Completed	`NCT04568395` - Acute Effects of TCIG vs ECIG in PLWH	N/A
Completed	`NCT03338933` - Neurobiology of Alcohol and Nicotine Co-Addiction
Completed	`NCT03634839` - Effects of E-cigarette Flavors on Youth TCORS 2.0	Phase 1
Recruiting	`NCT05515354` - Smoking Cessation and Menstrual Cycle Phase	Phase 4
Withdrawn	`NCT06259630` - Nicotine Virtual Reality Conditioned Place Preference	Phase 4
Recruiting	`NCT06170138` - Study to Assess PK, PD, Nicotine Extraction, Palatability, Subjective Effects of Nicotine Pouches - Daily Nicotine Users	N/A
Not yet recruiting	`NCT03264755` - Cortical Excitability and Role of rTMS in Nicotine Use Disorder	N/A
Recruiting	`NCT05766254` - Identify the Optimal TMS Target to Modulate Reward Activity	N/A
Completed	`NCT00330187` - Combined Pharmaco/Behavior Therapy in Adolescent Smokers	Phase 2
Completed	`NCT03635333` - Effects of E-Cigarette Flavors on Adults TCORS 2.0	Phase 1
Completed	`NCT03438188` - Neural Basis of Eating Behavior in Abstinent Smokers	N/A
Completed	`NCT03194958` - Helping Poor Smokers Quit	N/A
Not yet recruiting	`NCT05932745` - Effects of Novel E-cigarette Constituents on Adults TCORS 3.0	N/A
Recruiting	`NCT04432064` - Temporal Interference Neurostimulation and Addiction	N/A
Recruiting	`NCT05181891` - Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking	Phase 2
Active, not recruiting	`NCT05897242` - A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults	N/A
Not yet recruiting	`NCT05994209` - Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors	Phase 1
Terminated	`NCT03352609` - Accelerated rTMS for the Reduction of Nicotine Craving	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Real Time fMRI and Quitting Smoking

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms